Rothblatt Martine A

Chairperson &CEO

1 company

Good

Trades Analyzed

296

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 103 sells.

Estimated insider holdings value: $26.6M based on current market prices.

Holdings by Company

UTHRApr 20, 2026

Current Shares46.8K

Value$26.63M

Net Activity-320,269

Bought: 0Sold: 320.3K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 11, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$397.97	$3,183,776.80	-77.0%	+19.8%	-
Sep 9, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$398.55	$3,188,374.29	-79.2%	+18.7%	-
Aug 26, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	269	$348.41	$93,722.92	-24.5%	+6.3%	-10.8%
Aug 23, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$347.47	$2,501,765.36	-34.6%	+5.6%	-10.3%
Aug 21, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,292	$347.57	$2,534,510.30	-20.0%	+2.6%	-11.6%
Aug 19, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	3,600	$344.18	$1,239,047.37	-8.6%	+3.0%	-10.1%
Aug 16, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$322.00	$2,318,396.95	-30.0%	+20.3%	-2.4%
Aug 14, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$326.17	$2,348,425.50	-22.5%	+23.8%	-3.6%
Aug 12, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$332.31	$2,392,620.92	-30.0%	+20.0%	-9.7%
Aug 8, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$326.20	$2,348,641.20	-27.3%	+20.1%	-8.9%